UMC
0256 S0.300 ↓
0.300 ↓
-0.010 (-3.2%)| High | 0.310 |
| Low | 0.300 |
| Open | 0.310 |
| Volume | 7,000 |
| Volume (B/S) | 30,700 / 115,000 |
| Price Bid/Ask | 0.300 / 0.310 |
| 52w | 0.280 - 0.475 |
| ROE | 9.67 |
| P/E | 13.72 |
| EPS | 2.19 |
| DPS | 0.30 |
| DY | 1.00% |
| NTA | 0.2265 |
| P/B | 1.32 |
| RPS | 13.98 |
| PSR | 2.15 |
| Market Cap | 112.2M |
| Shares (mil) | 373.91 |
| RQoQ RYoY |
| CAGR % |
3Y
63.7%
TTM
2.9%
5Y
-52.8%
TTM
32.5%
|
| RSI(14) | Neutral 45.1 |
| Stochastic(14) | Neutral 33.3 |
| Stochastic RSI(14) | Neutral 60.2 |
| Average Volume (3M) | 122,600 |
| Relative Volume | 1.4 |
| Announced | Financial Year | Subject | EX Date | Payment Date | Amount | Indicator | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31 Jul, 2026 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 15 Jan 2026 | 31 Jul 2026 | First Interim Dividend | 29 Jan 2026 | 10 Feb 2026 | 0.0030 | Currency | View | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Announced | EX Date | Subject | Ratio | Offer |
|---|
No records
| Name | Price | Change | Volume | Gearing | Premium | Premium % | Maturity |
|---|
No warrants found.
Recent News
-
Rising demand to fuel UMedic Group’s expansion
UMedic Group Bhd expects growth momentum to be supported by expanding manufacturing capacity, a rising order book and new product initiatives over the coming years.TheStar -
Mixed outlook for UMediC amid earnings upgrade
Hong Leong Investment Bank (HLIB) Research remains cautious on UMediC Group Bhd despite raising its earnings forecasts, while Phillip Capital Research continues to see value in the healthcare product maker's longer-term growth prospects, underpinned by expansion plans and a stronger distribution business.TheStar -
【行家论股】税率利好提振盈利 UMediC末季复苏可期
UMediC集团(UMC,0256,创业板)近期公布2026财政年第3季业绩表现略优于丰隆投行的预期...Nanyang -
UMedic集团9个月净赚620万令吉
同期营运盈利上升17.7%,达1790万令吉,主要受惠于分销业务及制造业务贡献增加。...Nanyang -
惹上侵权官司 台积电晶片或被禁输美?
(华盛顿12日讯)美国网络媒体《Axios》报道,全球尖端晶片代工商——台积电(TSMC)卷入美国专利侵权诉讼风波。该案正被美国国际贸易委员会(ITC)审理,若ITC最终认定侵权成立,最严重可发布排除令,导致相关晶片产品被禁止进口美国。对此,台积电表示,该公司在所有营运所在地均遵守相关法律规Seehua
Recent Announcements
-
Quarterly rpt on consolidated results for the financial period ended 30/04/2026
-
WINDING UP / RECEIVER & MANAGER / RESTRAINING ORDER / SPECIAL ADMINISTRATOR
Commencement of Members' Voluntary Winding Up of Subsidiary -
Quarterly rpt on consolidated results for the financial period ended 31/01/2026
-
OTHERS
UMEDIC GROUP BERHAD ("UMC" OR "COMPANY") PROPOSED LEASE OF LAND -
UMC - Notice of Book Closure